AI Article Synopsis

  • NPRL2, a tumor suppressor, is often downregulated in glioma, leading to aggressive tumor growth and unclear interactions with immune cells.
  • The study investigates how NPRL2 influences the degradation of Galectin-3 (Gal-3) via TRIM16, affecting immune cell functions and copper uptake in CD8T lymphocytes.
  • Results show that NPRL2 enhances TRIM16 expression and reduces Gal-3 levels, which improves CD8T cell recruitment and protects them from Gal-3-related damage, suggesting a potential therapeutic target for restoring immune function in glioma.

Article Abstract

Background: Our previous study found that tumor suppressor nitrogen permease regulator like-2(NPRL2) is frequently downregulated in glioma, leading to malignant growth. However, NPRL2-mediated crosstalk between tumor cells and immune cells remains unclear.

Methods: The regulatory effects of NPRL2 on tripartite motif-containing protein 16(TRIM16) dependent ubiquitination degradation of Galectin-3(Gal-3) were explored. The effects of Gal-3 on copper uptake, immunocompetence and cuproptosis were investigated in CD8T lymphocytes(CD8T cells). The ability of NPRL2 to protect CD8T cells from Gal-3 damage was evaluated. Furthermore, the correlations among NPRL2, TRIM16, Gal-3 and CD8T cell accumulation were analyzed in glioma clinical specimens.

Results: NPRL2 increased the TRIM16 expression via inactivation of ERK1/2, which in turn promoted the ubiquitination-mediated degradation of Gal-3 and diminished Gal-3 release from glioma cells. Moreover, Gal-3 accelerated copper uptake and triggered cuproptosis in CD8T cells, whereas NPRL2 increased CD8T cell recruitment and prevented impairment of CD8T cells by Gal-3. Clinical samples revealed that NPRL2 expression was positively associated with TRIM16 expression and negatively correlated with Gal-3, but Gal-3 expression was negatively associated with CD8T cell accumulation.

Conclusion: Glioma-derived NPRL2/TRIM16/Gal-3 axis participates in the regulation of CD8T cell cuproptosis, which provides a promising strategy to rescue the immune activity of CD8T cells and reverse immunosuppression in glioma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11456027PMC
http://dx.doi.org/10.1007/s00018-024-05454-2DOI Listing

Publication Analysis

Top Keywords

cd8t cells
16
cd8t cell
16
cells gal-3
12
cd8t
10
gal-3
9
ubiquitination degradation
8
cells
8
copper uptake
8
nprl2 increased
8
trim16 expression
8

Similar Publications

SLAMF7 defines subsets of human effector CD8 T cells.

Sci Rep

December 2024

Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, 8A Biomedical Grove, Biopolis, Republic of Singapore.

Long-term control of viral replication relies on the efficient differentiation of memory T cells into effector T cells during secondary immune responses. Recent findings have identified T cell precursors for both memory and exhausted T cells, suggesting the existence of progenitor-like effector T cells. These cells can persist without antigenic challenge but expand and acquire effector functions upon recall immune responses.

View Article and Find Full Text PDF

Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis.

Hereditas

December 2024

Department of Pathology, Central Hospital of Zibo, No.54, Communist Youth League West Road, Zhangdian District, Zibo City, Shandong Province, 255000, China.

Background: Conventional treatments, including surgery, radiotherapy and chemotherapy, have many limitations in the prognosis of glioma patients. Atorvastatin (ATOR) has a significant inhibitory effect on glioma malignancy. Thus, ATOR may play a key role in the search for new drugs for the effective treatment of gliomas.

View Article and Find Full Text PDF

Ubiquitin-Activating Enzyme E1 (UBA1), an E1 enzyme involved in the activation of ubiquitin enzymes, has been involved in the onset and progression of different cancers in humans. Nevertheless, the precise contribution of in breast cancer (BC) is still poorly characterized. In this study, a thorough investigation was carried out to elucidate the significance of UBA1 and validate its functionality in BC.

View Article and Find Full Text PDF

In Vitro Evaluation of Bunyavirus T Cell Immunity.

Methods Mol Biol

December 2024

Pediatric Infectious Disease and Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Characterization and quantitation of T cell responses following infection and/or vaccination can provide insight into mechanisms of host cell immunity that provide resolution of acute infection or protection from future infection or disease. While these types of studies are very advanced for viruses such as HIV, influenza, and SARS-CoV-2, they are less well developed for most of the Bunyaviruses. Cytotoxic CD8T cells are especially relevant in the context of viral infections since they recognize virus-infected cells via interaction of the T cell receptor with virally derived peptides presented in the context of MHCI.

View Article and Find Full Text PDF

Background: Coronary heart disease is a common cardiovascular disease, yferroptosiset its relationship with iron metabolism remains unclear.

Methods: Gene expression data from peripheral blood samples of patients with coronary heart disease and a healthy control group were utilized for a comprehensive analysis that included differential expression analysis, weighted gene co-expression network analysis, gene enrichment analysis, and the development of a logistic regression model to investigate the associations and differences between the groups. Additionally, the CIBERSORT algorithm was employed to examine the composition of immune cell types within the samples.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!